𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A newly synthesized, potent tyrosinase inhibitor: 5-(6-Hydroxy-2-naphthyl)-1,2,3-benzenetriol

✍ Scribed by Jehun Choi; Sung Jin Bae; Young Mi Ha; Jae Kyung No; Eun Kyeong Lee; Jun Sik Lee; Suhee Song; Hyojin Lee; Hongsuk Suh; Byung Pal Yu; Hae Young Chung


Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
351 KB
Volume
20
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

✦ Synopsis


In searching for new agents with a depigmenting effect, we synthesized a derivative of resveratrol, 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol (5HNB) with a potent tyrosinase inhibitory activity.

5HNB inhibited mushroom tyrosinase with an IC 50 value of 2.95 lM, which is more potent than the well-known anti-tyrosinase activity of kojic acid (IC 50 = 38.24). The results of the enzymatic inhibition kinetics by Lineweaver-Burk analysis indicated 5HNB inhibits tyrosinase non-competitively when


πŸ“œ SIMILAR VOLUMES


Corrigendum to β€œA newly synthesized, pot
✍ Jehun Choi; Sung Jin Bae; Young Mi Ha; Jae Kyung No; Eun Kyeong Lee; Jun Sik Lee πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 139 KB

The authors regret that this article contains one error. The structure of Kojic acid (4) was revised. Therefore, the following correction should be made.

Syntheses of isotopically labeled 4-[1-(
✍ Lin Zhang; Beth Ann Badea; Debra Enyeart; Elaine M. Berger; Dale E. Mais; Marcus πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 576 KB

## Abstract LGD1069, 4‐[1‐(3,5,5,8,8‐pentamethyl‐5,6,7,8‐tetrahydro‐2‐naphthyl)ethenyl] benzoic acid, is the first retinoid X receptor (RXR) selective retinoid to enter clinical trials for treatment of dermatological diseases and cancer. In order to examine biological properties such as receptor bi